Abstract: Aims. Several treatments have been proposed to slow down progression of Retinitis pigmentosa (RP), a hereditary retinal degenerative condition leading to severe visual impairment. The aim of this study is to systematically review data from randomized...
Retinitis Pigmentosa
Hyperbaric Oxygen Therapy (HBOT) Research for Retinitis Pigmentosa
Recent advances in treatment of retinitis pigmentosa.
Abstract: Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide....
Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.
Abstract: Retinitis pigmentosa (RP) therapy is still an unsolved challenge. Recent reports have underlined that hyperbaric oxygen (HBO) therapy could play a role in slowing the retinal degenerative process. The aim of this study was to assess the efficacy of HBO...
Retinal degeneration and local oxygen metabolism.
Abstract: Vision loss due to various forms of outer retinal degeneration remains a major problem in clinical ophthalmology. Most retinal degenerations are precipitated by genetic mutations affecting the retinal pigment epithelium and sensory retina, but it is becoming...
Does hyperbaric oxygen (HBO) delivery rescue retinal photoreceptors in retinitis pigmentosa?
Abstract: As previously reported in the literature, hyperbaric oxygen delivery seems to modify the natural course of retinitis pigmentosa. In order to evaluate these first encouraging data, 48 affected subjects were separately studied in two subgroups (cases and...
[Treatment with hyperbaric oxygen. Illustrated by the treatment of a patient with retinitis pigmentosa].
Abstract: A 26 year old man, who was physically fit and occupationally active but had retinitis pigmentosa and a slight hearing impairment, received hyperbaric oxygen treatment for 97 minutes at a pressure of 240 kPA for five days a week over a period of four weeks....
[Hyperbaric oxygenation therapy in retinitis pigmentosa].
Abstract: Gisholt, , , , , , , , (1993). [Hyperbaric oxygenation therapy in retinitis pigmentosa]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1993 Jun;113(15):1883-4. https://www.ncbi.nlm.nih.gov/pubmed/8322335
[Maculopathy in typical retinitis pigmentosa apropos of 33 cases].
Abstract: The authors studied 33 maculopathies in 54 patients affected by typic retinitis pigmentosa: atrophic macular degeneration 31 cases (49%); cystoïd macular oedema: 1 case (3%) and macular retraction syndrome: 1 case (3%). These results are confronted with...
[Retinitis pigmentosa and hyperbaric oxygen therapy].
Abstract: Vérin, Comte, Poisot, , , , , , (). [Retinitis pigmentosa and hyperbaric oxygen therapy]. Bulletin des societes d'ophtalmologie de France, ;86(8-9):1071-2, 1074. https://www.ncbi.nlm.nih.gov/pubmed/3568248